Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$1.12B |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$358M |
| 3 |
NVIDIA
NVDA
|
+$293M |
| 4 |
Coca-Cola
KO
|
+$290M |
| 5 |
iShares US Pharmaceuticals ETF
IHE
|
+$220M |
Top Sells
| 1 |
SI
SIEMENS AKTIENGESELLSCHAFT ADS
SI
|
+$828M |
| 2 |
ABB
ABB Ltd.
ABB
|
+$679M |
| 3 |
NextEra Energy, Inc.
NEE
|
+$590M |
| 4 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$253M |
| 5 |
PepsiCo
PEP
|
+$230M |
Sector Composition
| 1 | Technology | 30% |
| 2 | Financials | 12.45% |
| 3 | Consumer Discretionary | 10.07% |
| 4 | Healthcare | 9.87% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
Movado Group
MOV
$426M
| $952K | ﹤0.01% |
31,582
| – | – |
|
702
Build-A-Bear
BBW
$962M
| $946K | ﹤0.01% |
41,152
| – | – |
|
703
Phillips 66
PSX
$53.1B
| $934K | ﹤0.01% |
7,012
-1,223
| -15% | -$163K |
|
704
SPDR Gold Trust
GLD
$115B
| $933K | ﹤0.01% |
4,879
-313
| -6% | -$59.8K |
|
705
A10 Networks
ATEN
$1.26B
| $921K | ﹤0.01% |
69,910
-9,918
| -12% | -$131K |
|
706
Entravision Communication
EVC
$215M
| $918K | ﹤0.01% |
220,143
-30,202
| -12% | -$126K |
|
707
Genpact
G
$7.49B
| $905K | ﹤0.01% |
26,074
-4,568
| -15% | -$159K |
|
708
Anika Therapeutics
ANIK
$121M
| $875K | ﹤0.01% |
38,620
-2,105
| -5% | -$47.7K |
|
709
Schwab US Large- Cap ETF
SCHX
$59.8B
| $870K | ﹤0.01% |
46,281
+1,083
| +2% | +$20.4K |
|
710
Celldex Therapeutics
CLDX
$1.66B
| $865K | ﹤0.01% |
21,812
+1,274
| +6% | +$50.5K |
|
711
iShares US Telecommunications ETF
IYZ
$610M
| $853K | ﹤0.01% |
37,498
+2,181
| +6% | +$49.6K |
|
712
Sutro Biopharma
STRO
$77.2M
| $843K | ﹤0.01% |
196,517
| – | – |
|
713
United Therapeutics
UTHR
$17.9B
| $842K | ﹤0.01% |
3,828
+209
| +6% | +$46K |
|
714
Fidelity MSCI Health Care Index ETF
FHLC
$2.45B
| $835K | ﹤0.01% |
12,913
-414
| -3% | -$26.8K |
|
715
Weyerhaeuser
WY
$18.1B
| $835K | ﹤0.01% |
24,002
+13,632
| +131% | +$474K |
|
716
SPDR Bloomberg International Corporate Bond ETF
IBND
$463M
| $823K | ﹤0.01% |
+27,489
| New | +$823K |
|
717
iShares US & Intl High Yield Corp Bond ETF
GHYG
$176M
| $819K | ﹤0.01% |
+18,505
| New | +$819K |
|
718
Amdocs
DOX
$9.23B
| $811K | ﹤0.01% |
9,223
-1,799
| -16% | -$158K |
|
719
Mondelez International
MDLZ
$80.6B
| $810K | ﹤0.01% |
11,189
-2,187
| -16% | -$158K |
|
720
Philip Morris
PM
$257B
| $807K | ﹤0.01% |
8,573
-3,522
| -29% | -$331K |
|
721
Schwab International Equity ETF
SCHF
$50.9B
| $803K | ﹤0.01% |
43,464
-27,722
| -39% | -$512K |
|
722
KLA
KLAC
$123B
| $799K | ﹤0.01% |
1,374
+195
| +17% | +$113K |
|
723
Wabtec
WAB
$32.4B
| $794K | ﹤0.01% |
6,254
-96
| -2% | -$12.2K |
|
724
iShares TIPS Bond ETF
TIP
$14B
| $790K | ﹤0.01% |
7,346
+635
| +9% | +$68.3K |
|
725
Vanguard Mid-Cap ETF
VO
$87.4B
| $788K | ﹤0.01% |
3,387
+49
| +1% | +$11.4K |
|